Cyclacel Pharmaceuticals, Inc. (CYCC)

NASDAQ: CYCC · IEX Real-Time Price · USD
2.800
+0.170 (6.46%)
Feb 26, 2024, 12:03 PM EST - Market open

Cyclacel Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2001
Revenue
00000.1500.841.941.731.08
Upgrade
Revenue Growth (YoY)
-------56.64%12.11%59.96%1471.01%
Upgrade
Gross Profit
00000.1500.841.941.731.08
Upgrade
Selling, General & Admin
7.387.465.885.025.375.255.525.735.897.78
Upgrade
Research & Development
20.2714.934.764.664.334.249.4812.3818.2811.28
Upgrade
Operating Expenses
27.6622.3910.649.689.79.4914.9918.1124.1719.06
Upgrade
Operating Income
-27.66-22.39-10.64-9.68-9.55-9.49-14.15-16.17-22.44-17.97
Upgrade
Other Expense / Income
-1.74-0.2-0.96-0.56-0.92-1.03-0.380.320.19-6.15
Upgrade
Pretax Income
-25.92-22.19-9.68-9.13-8.63-8.46-13.77-16.49-22.63-11.82
Upgrade
Income Tax
-4.72-3.73-1.24-1.3-1.34-0.99-1.98-2.14-3.24-1.67
Upgrade
Net Income
-21.2-18.46-8.45-7.83-7.29-7.47-11.79-14.34-19.39-10.15
Upgrade
Preferred Dividends
0.20.23.980.20.27.380.20.20.29.33
Upgrade
Net Income Common
-21.4-18.66-12.42-8.03-7.49-14.85-11.99-14.54-19.59-19.48
Upgrade
Shares Outstanding (Basic)
1100000000
Upgrade
Shares Outstanding (Diluted)
1100000000
Upgrade
Shares Change
26.10%145.67%345.23%34.95%58.49%122.80%26.24%48.29%44.83%82.85%
Upgrade
EPS (Basic)
-28.65-31.35-51.30-147.60-186.00-585.00-1050.00-1608.00-3204.00-4608.00
Upgrade
EPS (Diluted)
-28.65-31.35-51.30-147.60-186.00-585.00-1050.00-1608.00-3204.00-4608.00
Upgrade
Free Cash Flow
-20.83-18.57-8.03-9.42-6.74-7.49-10.07-14.49-19.01-18.41
Upgrade
Free Cash Flow Per Share
-27.77-31.20-33.15-173.13-167.19-294.57-882.05-1602.67-3117.21-4371.57
Upgrade
Gross Margin
----100.00%-100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-----6365.33%--1678.53%-831.79%-1293.94%-1658.12%
Upgrade
Profit Margin
-----4992.67%--1422.42%-748.10%-1129.58%-1796.86%
Upgrade
Free Cash Flow Margin
-----4493.33%--1194.54%-745.58%-1096.37%-1698.06%
Upgrade
EBITDA
-25.88-22.14-9.66-9.11-8.6-8.43-13.64-16.28-22.46-11.75
Upgrade
EBITDA Margin
-----5730.67%--1618.15%-837.24%-1295.04%-1084.23%
Upgrade
Depreciation & Amortization
0.030.040.020.020.030.030.130.210.170.07
Upgrade
EBIT
-25.92-22.19-9.68-9.13-8.63-8.46-13.77-16.49-22.63-11.82
Upgrade
EBIT Margin
-----5750.00%--1633.93%-848.05%-1305.07%-1090.68%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).